Ashutosh Dalvi - Publications

Affiliations: 
1998-1999 Psychiatry University of Pennsylvania, Philadelphia, PA, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 101: 8186-91. PMID 15148402 DOI: 10.1073/Pnas.0401080101  0.719
2002 Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist. The Journal of Pharmacology and Experimental Therapeutics. 302: 1220-7. PMID 12183683 DOI: 10.1124/Jpet.102.034280  0.619
2002 Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3262-8. PMID 11943827 DOI: 10.1523/Jneurosci.22-08-03262.2002  0.665
2002 Graves L, Dalvi A, Lucki I, Blendy JA, Abel T. Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background. Hippocampus. 12: 18-26. PMID 11918283 DOI: 10.1002/Hipo.10003  0.564
2001 Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. The Journal of Pharmacology and Experimental Therapeutics. 298: 1101-7. PMID 11504807  0.579
2001 Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. The Journal of Pharmacology and Experimental Therapeutics. 298: 651-7. PMID 11454927  0.668
2001 Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology. 155: 315-22. PMID 11432695 DOI: 10.1007/S002130100694  0.59
2000 Yang J, Wu J, Kowalska MA, Dalvi A, Prevost N, O'Brien PJ, Manning D, Poncz M, Lucki I, Blendy JA, Brass LF. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proceedings of the National Academy of Sciences of the United States of America. 97: 9984-9. PMID 10954748 DOI: 10.1073/Pnas.180194597  0.522
2000 Lucki I, Cryan JF, Kirby LG, Dalvi A. The role of norepinephrine and serotonin in behavioral models of depression Psychoneuroendocrinology. 25: S23. DOI: 10.1016/S0306-4530(00)90103-3  0.689
1999 Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology. 147: 162-7. PMID 10591883 DOI: 10.1007/S002130051156  0.693
1999 Dalvi A, Lucki I. Murine models of depression. Psychopharmacology. 147: 14-6. PMID 10591858 DOI: 10.1007/S002130051131  0.544
1999 Dalvi A, Rodgers RJ. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance. Pharmacology, Biochemistry, and Behavior. 62: 727-34. PMID 10208379 DOI: 10.1016/S0091-3057(98)00220-2  0.355
Show low-probability matches.